Abstract
Rapid liquid chromatographic procedures for analytical quality control of pharmaceutical preparations and human serum containing antihistamine drugs, meclizine and buclizine alone or in combination with pyridoxine are proposed, using acetonitrile:water (80:20) as a mobile phase (pH adjusted to 2.6), methylparaben as internal standard and UV detection was made at 230 nm. The results obtained showed a good agreement with the declared content. The method shows good linearity in the range of 30–10,000 ng mL−1 for pyridoxine and 25–10,000 ng mL−1 for meclizine and buclizine serum concentrations with a correlation coefficient 0.9999 (inter- and intra-day CV < 3.91%). The recovery was >97.8%. The proposed method may be used for the quantitative analysis of meclizine and buclizine alone or in combination with pyridoxine from raw materials, in bulk drugs, dosage formulations and in serum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
The Merck index (2001) An Encyclopedia of Chemical, Drugs and Biologicals, 13th edn. Merck Research Laboratories. Division of Merck & Co Inc. Whitehouse Station, NJ, pp 245, 1032, 429
Martindale, The extra pharmacopoeia. 31st edn. (1996) Royal Pharmaceutical society of Great Britain, 1 Lambeth High street London SE17 Jn England, pp 435–436, 447, 1384
British Pharmacopoeia (2003) The Stationary office under license from the controller of Her Majesty’s stationary office for the department of health on behalf of the health Ministers, pp 272, 1195, 1595
El-gindy A, el-Yazby F, Mostafa A, Maher MM (2003) J Pharm Biomed Anal 32(2):277–286
Jedlicka A, Klimes J (2004) Ceska Slov Farm 53(5):243–7
Heudi O, Kilinic T, Fontannaz P (2005) J Chromatogr A 1070(1–2):49–56
Mirza MJ, Lunn FJ, Keeley RC, George JR, Bodenmiller (1999) J Pharm Biomed Anal 19(5):747–756
El-Gindy A, el-Yazby F, Mostafa A, Maher MM (2004) J Pharm Biomed Anal 35(4):703–713
Hadjmohammadi MR, Momenbeik F, Khorasani JH (2004) Ann Chim 94(11):857–66
Chatzimichalakis PF, Samanidou VF, Verpoorte R, Papadoyannis IN (2004) J Sep Sci 27(14):1181–1188
Arayne MS, Sultana N, Siddiqui FA (2006) Pak J Pharm Sci 19(4):326–329
El Walily AF, El Gindy A, Bedair MF (1999) J Pharm Biomed Anal 21(3):535–548
Lebiedzinska A, Czarnowski W, Szefer P (2005) J Chromatogr A 1094(1–2):91–8
Rybak ME, Jain RB, Pfeiffer CM (2005) Clin Chem 51(7):1223–1231
Rybak ME, Pfeiffer CM (2004) Anal Biomed 333(2):336–44
Li K (2002) Biomed Chromatogr 16(8):504–507
Markopoulou CK, Kagkadis KA, Koundourellis JE (2002) J Pharm Biomed Anal 30(4):1403–1410
Martinez-Algaba C, Bermudez-Saldana JM, Villanueva-Camanas RM, Sagrado S, Medina-Hernandez MJ (2006) J Pharm Biomed Anal 40(2):312–321
Arayne MS, Sultana N, Siddiqui FA, Zuberi MH, Mirza AZ (2007) Pak J Pharm Sci 20(2):149–156
International Conference on the Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Q2B (1996) Validation of Analytical Procedures, Methodology, 1996
United States Pharmacopeia 26 (USP 26) (2002) Validation of Compendial Methods, United States Pharmacopeia Convention: Rockville 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arayne, M.S., Sultana, N. & Siddiqui, F.A. Simultaneous Determination of Pyridoxine, Meclizine and Buclizine in Dosage Formulations and Human Serum by RP-LC. Chroma 67, 941–945 (2008). https://doi.org/10.1365/s10337-008-0615-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0615-5